Disease severity is not predictive of the dose required for apomorphine sublingual film (APL-130277) to convert a patient with Parkinson's disease (PD) from OFF to fully ON: preliminary results from a phase iii study Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Fernandez, H
  • Isaacson, S
  • Espay, A
  • Pahwa, R
  • Truong, D
  • Pappert, E
  • Gardzinski, P
  • Dzyngel, B
  • Agro, Albert
  • Hauser, R

publication date

  • June 1, 2017